Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (ENOV)
NYSE:ENOV
Enovis (ENOV) Stock Price & Analysis
234 Followers
ENOV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$43.04 - $66.14
Previous Close$52.41
Volume335.78K
Average Volume (3M)512.66K
Market Cap
$2.87B
Enterprise Value$3.31B
Total Cash (Recent Filing)$36.19M
Total Debt (Recent Filing)$466.16M
Price to Earnings (P/E)-29.4
Beta1.16
Next Earnings
Aug 01, 2024EPS Estimate
$0.6Last Dividend Ex-Date
Apr 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-1.78
Shares Outstanding54,850,906
10 Day Avg. Volume619,349
30 Day Avg. Volume512,664
Standard Deviation0.11
R-Squared0.60
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)12.44
Price to Sales (P/S)1.68
Price to Cash Flow (P/CF)10.50
P/FCF Ratio17.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.94
Enterprise Value/Gross Profit3.34
Enterprise Value/Ebitda19.48
Forecast
1Y Price Target
$76.00Price Target Upside45.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Enovis News
Bulls Say, Bears Say
Bulls Say
Financial Performance & Analyst ConfidenceWith recent quarterly earnings surpassing expectations and management confidently raising future guidance, Enovis demonstrates strong financial health and robust growth prospects, earning an Outperform rating from analysts.
Market Leadership & Growth PotentialEnovis is expanding its influence in the multi-billion dollar prevention & recovery and global orthopedic implant markets, signaling potential for significant market share gains and long-term growth.
Strategic Acquisitions & SynergyThe successful integration of the Lima acquisition and positive investor feedback highlight Enovis's effective strategy in driving revenue and cost synergies, which could lead to further expansion and market dominance.
Bears Say
Earnings GuidanceCore 2024 EPS guidance is below analyst and Street expectations, attributed to higher depreciation and tax rate.
Financial PerformanceEarly revenue dis-synergies and cash flow pressures tied to early Lima integration efforts.
Sales PerformanceEMBLA's Bracing & Support sales only increased 1% organically, below the analyst's estimate of 3.5% for ENOV's P&R business in Q1.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ENOV FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest stock price was $43.04 and its highest was $66.14 in the past 12 months.
What is Enovis’s market cap?
Currently, no data Available
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Aug 01, 2024 which is in 74 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on May 02, 2024. The company reported $0.5 earnings per share for the quarter, beating the consensus estimate of $0.484 by $0.016.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis pays a Notavailable dividend of $16.67 which represents an annual dividend yield of N/A. See more information on Enovis dividends here
What is Enovis’s EPS estimate?
Enovis’s EPS estimate is $0.6.
How many shares outstanding does Enovis have?
Enovis has 54,850,906 shares outstanding.
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.5 in its last earnings report, beating expectations of $0.484. Following the earnings report the stock price went down -5.903%.
Which hedge fund is a major shareholder of Enovis?
Among the largest hedge funds holding Enovis’s share is Diamond Hill Capital Management Inc. It holds Enovis’s shares valued at 152M.
---
Enovis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$76.00 (45.01% Upside)
$76.00 (45.01% Upside)
Blogger Sentiment
Bullish
ENOV Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 119.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.05%
12-Months-Change
Fundamentals
Return on Equity
-3.06%
Trailing 12-Months
Asset Growth
27.42%
Trailing 12-Months
Company Description
Enovis
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
---
ENOV Company Deck
---
ENOV Earnings Call
Q1 2024
0:00 / 0:00
---
ENOV Stock 12 Month Forecast
Average Price Target
$76.00
▲(45.01% Upside)
Technical Analysis
Best Analysts Covering ENOV
1 Year
---